PROBUPREN
associated with 34 other trademarks
Pharmaceuticals, namely, implantable drug delivery system comprised primarily of sustained release drugs in the treatment of cancer, central nervous s...

Words that describe this trademark:

sustained release drugs  drug delivery system  implantable drug delivery  delivery system  drugs treatment  release drugs  system  pharmaceuticals  primarily  comprised 

Serial Number:

76281258

Mark:

PROBUPREN

Status:

Abandoned-No Statement of Use filed

Status Date:

04-09-2003

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceuticals, namely, implantable drug delivery system comprised primarily of sustained release drugs in the treatment of cancer, central nervous system disorders, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disorders, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and other disorders of the immune system, infectious disease and enzyme deficiency diseases

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

07-16-2002

Mark Drawing Status:

Typed Drawing

Abandon Date:

04-09-2003

Business Name:

MORRISON & FOERSTER LLP

Correspondent Name:

Recent Trademark filings by this company